A primary, structural driver of the sustained growth in the In Vitro Diagnostics (IVD) Market is the escalating global prevalence of chronic diseases coupled with the rapid aging of the population. As populations age, the incidence of conditions such as diabetes, cardiovascular disease (CVD), chronic kidney disease (CKD), and various cancers increases exponentially. These diseases are not...